Physical activity measured with implanted devices predicts patient outcome in chronic heart failure

Circulation: Heart Failure

Volumn 7, Issue 2, 2014, Pages 279-287

  Conraads, Viviane M ^a,b   Spruit, Martijn A ^c,d   Braunschweig, Frieder ^e   Cowie, Martin R ^f   Tavazzi, Luigi ^g   Borggrefe, Martin ^h   Hill, Michael R S ⁱ   Jacobs, Sandra ^j   Gerritse, Bart ^j   Van Veldhuisen, Dirk J ^k  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c CIRO+   (Netherlands)

^d HASSELT UNIVERSITY   (Belgium)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^g MARIA CECILIA HOSPITAL   (Italy)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ MEDTRONIC INC   (United States)

^j MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^k UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

Heart failure; Mortality; Physical activity

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACCELEROMETER; ADULT; AGED; AGING; ARTICLE; BODY HEIGHT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MORTALITY; CRACKLE; DEATH; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT MONITORING; PERIPHERAL EDEMA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; SENSOR; WALKING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HEALTH; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MORTALITY; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME;

HEART FAILURE; MORTALITY; PHYSICAL ACTIVITY;

AGED; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MOTOR ACTIVITY; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; WORLD HEALTH;

EID: 84899997150     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.113.000883     Document Type: Article

References (45)

1. Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): The association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376:886-894.
2. Meta-analysis Global Group in Chronic Heart F. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: An individual patient data meta-analysis. Eur Heart J. 2012;33:1750-1757.
3. Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace. 2011;13(suppl 2):ii13-ii17.
4. Paffenbarger RS Jr, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med. 1993;328:538-545.
5. Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA. 1995;273:1093-1098.
6. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801.
7. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J; European Association for Cardiovascular Prevention and Rehabilitation; American Heart Association. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126:2261-2274.
8. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Kitzman D, Peberdy MA, Bensimhon D, Chase P, Forman DE, Guazzi M. Defining the optimal prognostic window for cardiopulmonary exercise testing in patients with heart failure. Circ Heart Fail. 2010;3:405-411.
9. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: A population based cohort study. Thorax. 2006;61:772-778.
10. Johansen KL, Kaysen GA, Dalrymple LS, Grimes BA, Glidden DV, Anand S, Chertow GM. Association of physical activity with survival among ambulatory patients on dialysis: The Comprehensive Dialysis Study. Clin J Am Soc Nephrol. 2013;8:248-253.
11. Waschki B, Kirsten A, Holz O, MÜller KC, Meyer T, Watz H, Magnussen H. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: A prospective cohort study. Chest. 2011;140:331-342.
12. Walsh JT, Charlesworth A, Andrews R, Hawkins M, Cowley AJ. Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. Am J Cardiol. 1997;79:1364-1369.
13. Jehn M, Schmidt-Trucksäss A, Schuster T, Weis M, Hanssen H, Halle M, Koehler F. Daily walking performance as an independent predictor of advanced heart failure: prediction of exercise capacity in chronic heart failure. Am Heart J. 2009;157:292-298.
14. Howell J, Strong BM, Weisenberg J, Kakade A, Gao Q, Cuddihy P, Delisle S, Kachnowski S, Maurer MS. Maximum daily 6 minutes of activity: An index of functional capacity derived from actigraphy and its application to older adults with heart failure. J Am Geriatr Soc. 2010;58:931-936.
15. Shoemaker MJ, Curtis A, Vangsnes E, Dickinson M, Paul R. Analysis of daily activity data from implanted cardiac defibrillators: The minimum clinically important difference and relationship to mortality/life expectancy. World J Cardiovasc Dis. 2012;2:129-135.
16. Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: The SENSE-HF trial. Eur Heart J. 2011;32:2266-2273.
17. van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, Kautzner J, Aguilera RM, Lunati M, Yu CM, Gerritse B, Borggrefe M; DOT-HF Investigators. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011;124:1719-1726.
18. Cowie MR, Conraads V, Tavazzi L, Yu CM; SENSE-HF Investigators. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: The SENSE-HF study. J Card Fail. 2009;15:394-400.
19. Braunschweig F, Ford I, Conraads V, Cowie MR, Jondeau G, Kautzner J, Lunati M, Munoz Aguilera R, Man Yu C, Marijianowski M, Borggrefe M, van Veldhuisen DJ; DOT-HF Steering Committee and Investigators. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). Eur J Heart Fail. 2008;10:907-916.
20. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American Heart Association. Circulation. 2009;119:2408-2416.
21. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27:65-75.
22. Harrell FE Jr. Regression Modeling Strategies. Springer: New York; 2001.
23. Aspenes ST, Nilsen TI, Skaug EA, Bertheussen GF, Ellingsen O, Vatten L, Wisloff U. Peak oxygen uptake and cardiovascular risk factors in 4631 healthy women and men. Med Sci Sports Exerc. 2011;43:1465-1473.
24. Myers J, Kaykha A, George S, Abella J, Zaheer N, Lear S, Yamazaki T, Froelicher V. Fitness versus physical activity patterns in predicting mortality in men. Am J Med. 2004;117:912-918.
25. Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Stadler RW, Shih A, Rhodes MM; InSync III Model 8042 and Attain OTW Lead Model 4193 Clinical Trial Investigators. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. 2004;110:2389-2394.
26. Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, Labeau M, Koehler J, Sarkar S, Hettrick DA, Tang WH. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. 2009;15:475-481.
27. Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from partners hf (program to access and review trending information and evaluate correlation to symptoms in patients with heart failure) study. J Am Coll Cardiol. 2010;55:1803-1810.
28. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424-1433.
29. Keteyian SJ, Leifer ES, Houston-Miller N, Kraus WE, Brawner CA, O'Connor CM, Whellan DJ, Cooper LS, Fleg JL, Kitzman DW, Cohen- Solal A, Blumenthal JA, Rendall DS, Piña IL; HF-ACTION Investigators. Relation between volume of exercise and clinical outcomes in patients with heart failure. J Am Coll Cardiol. 2012;60:1899-1905.
30. Witham MD, Argo IS, Johnston DW, Struthers AD, McMurdo ME. Predictors of exercise capacity and everyday activity in older heart failure patients. Eur J Heart Fail. 2006;8:203-207.
31. De Feo S, Franceschini L, Brighetti G, Cicoira M, Zanolla L, Rossi A, Golia G, Zardini P. Ischemic etiology of heart failure identifies patients with more severely impaired exercise capacity. Int J Cardiol. 2005;104:292-297.
32. Forman DE, Clare R, Kitzman DW, Ellis SJ, Fleg JL, Chiara T, Fletcher G, Kraus WE; HF-ACTION Investigators. Relationship of age and exercise performance in patients with heart failure: The HF-ACTION study. Am Heart J. 2009;158(4 suppl):S6-S15.
33. Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, Kim SG, Martin LW, Rosenberg Y, Wyse DG; AFFIRM Investigators. Functional status in rate-versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy. J Am Coll Cardiol. 2005;46:1891-1899.
34. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial. Lancet. 2000;356:1789-1794.
35. Izawa KP, Watanabe S, Oka K, Osada N, Omiya K, Brubaker PH, Shimizu H. Diabetes mellitus may lower daily physical activity in heart failure patients. Int J Cardiol. 2013;168:4882-4883.
36. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, Clarke K. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation. 2003;107:3040-3046.
37. Crowther RG, Spinks WL, Leicht AS, Quigley F, Golledge J. Relationship between temporal-spatial gait parameters, gait kinematics, walking performance, exercise capacity, and physical activity level in peripheral arterial disease. J Vasc Surg. 2007;45:1172-1178.
38. Jones WS, Clare R, Ellis SJ, Mills JS, Fischman DL, Kraus WE, Whellan DJ, O'Connor CM, Patel MR. Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF- ACTION). Am J Cardiol. 2011;108:380-384.
39. Lapu-Bula R, Robert A, Van Craeynest D, D'Hondt AM, Gerber BL, Pasquet A, Melin JA, De Kock M, Vanoverschelde JL. Contribution of exercise-induced mitral regurgitation to exercise stroke volume and exercise capacity in patients with left ventricular systolic dysfunction. Circulation. 2002;106:1342-1348.
40. Abdulla J, Abildstrom SZ, Christensen E, Kober L, Torp-Pedersen C. A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction. Eur J Heart Fail. 2004;6:927-935.
41. Guazzi M, Arena R. The impact of pharmacotherapy on the cardiopulmonary exercise test response in patients with heart failure: A mini review. Curr Vasc Pharmacol. 2009;7:557-569.
42. Guazzi M, Melzi G, Marenzi GC, Agostoni P. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction. Clin Pharmacol Ther. 1999;65:319-327.
43. Poelzl G, Frick M, Lackner B, Huegel H, Alber HF, Mair J, Herold M, Schwarzacher SP, Pachinger O, Weidinger F. Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function. Int J Cardiol. 2006;108:48-54.
44. Gulati SK, McKenzie J, Crossley G, Papp MA, Sims J, Andriulli J. Device measured physical activity: Is it the new 6-minute hall walk? J Cardiac Failure. 2009;15:S119-S120.
45. Braunschweig F, Mortensen PT, Gras D, Reiser W, Lawo T, Mansour H, Sogaard P, Stegemann B, Bruns HJ, Linde C; InSync III Study Investigators. Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices. Am J Cardiol. 2005;95:1104-1107.